greeksoup/ stock research
Stock research / United States / BBIO / Planned sales

BridgeBio Pharma, Inc. planned insider sales

In the last twelve months insiders at BridgeBio Pharma, Inc. filed 32 Form 144 notices of planned sales, 1.5 million shares worth $110.3 million at the time of filing, from 13 sellers. The latest, filed 19 August 2026: Kumar Haldea Family Irrevocable Tru/T/A DTD 05/18/2019 (director, officer), 30,000 shares worth $2.5 million, planned for around 19 August 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

FiledSellerRelationshipSharesValuePlanned saleSold, per Form 4BrokerHow acquiredFiling
19 August 2026Kumar Haldea Family Irrevocable Tru/T/A DTD 05/18/2019Director, Officer30,000$2.5 million19 August 2026None on Form 4 yetMorgan Stanley Smith Barney LLC Executive Financial ServicesConversion Management Incentive UnitsForm 144
18 August 2026Neil KumarDirector, Officer34,980$2.8 million18 August 202654,980 shares from 18 August 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
17 August 2026Randal ScottDirector21,501$1.7 million17 August 2026None on Form 4 yetMorgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
9 July 2026Andrea EllisDirector17,167$1.4 million9 July 202617,167 shares from 9 July 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
9 July 2026Jennifer CookDirector148,589$13.2 million9 July 2026148,589 shares from 9 July 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
24 June 2026Randal ScottDirector2,196$150,71124 June 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
24 June 2026Jennifer CookDirector37,167$2.6 million24 June 202639,363 shares from 23 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
23 June 2026Jennifer CookDirector2,196$150,58023 June 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesRestricted StockForm 144
23 June 2026Hannah A ValantineDirector2,196$150,58023 June 20265,004 shares from 22 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted StockForm 144
22 June 2026Hannah A ValantineDirector2,808$190,94422 June 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
15 June 2026Jennifer CookDirector90,240$6.0 million15 June 202690,240 shares from 15 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock; Stock Option ExerciseForm 144
21 May 2026Neil KumarDirector, Officer26,103$1.8 million21 May 2026106,103 shares from 21 May 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
18 May 2026Thomas TrimarchiOfficer13,651$888,41918 May 202613,651 shares from 18 May 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted StockForm 144
9 April 2026Kumar Haldea Revocable Trust U/A DTD 12/19/2018Director, Officer120,000$8.9 million9 April 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesConversion Management Incentive UnitsForm 144
13 March 2026Kumar Haldea Family Irrevocable TrustDirector, Officer140,000$9.5 million13 March 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesConversion Management Incentive UnitsForm 144
10 March 2026Hannah A ValantineDirector8,671$624,31210 March 20268,671 shares from 10 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
4 March 2026Andrea EllisDirector64,921$4.2 million4 March 202664,921 shares from 4 March 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
27 February 2026Hannah A ValantineDirector25,484$1.7 million27 February 202625,484 shares from 27 February 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
19 February 2026Neil KumarDirector, Officer28,053$2.1 million19 February 2026268,053 shares from 19 February 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
17 February 2026Thomas TrimarchiOfficer13,600$1.0 million17 February 202613,600 shares from 17 February 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted StockForm 144
17 February 2026Randal ScottDirector20,000$1.5 million17 February 202620,000 shares from 17 February 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
8 January 2026Kumar Haldea Family Irrevocable TrustDirector, Officer100,000$7.4 million8 January 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesConversion Management Incentive UnitsForm 144
8 January 2026Kumar Haldea Revocable Trust U/A DTD 12/19/2018Director, Officer120,000$8.9 million8 January 2026No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesConversion Management Incentive UnitsForm 144
15 December 2025Neil KumarDirector, Officer30,011$2.3 million15 December 2025190,011 shares from 15 December 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
20 November 2025Neil KumarDirector, Officer26,156$1.7 million20 November 2025106,156 shares from 20 November 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
18 November 2025Andrew W LoDirector55,000$3.6 million18 November 202595,599 shares from 17 November 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted StockForm 144
17 November 2025Randal ScottDirector10,000$663,90017 November 202510,000 shares from 17 November 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
17 November 2025Thomas TrimarchiOfficer16,934$1.1 million17 November 202516,934 shares from 17 November 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted StockForm 144
17 November 2025Andrew W LoDirector40,599$2.7 million17 November 2025No matching Form 4 saleMorgan Stanley Smith Barney LLC Executive Financial ServicesRestricted StockForm 144
12 November 2025Hannah A ValantineDirector25,484$1.7 million12 November 202525,484 shares from 12 November 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
6 November 2025Ronald J DanielsDirector61,031$3.9 million6 November 202561,031 shares from 6 November 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesStock Option ExerciseForm 144
29 October 2025Frank McCormickDirector198,359$13.2 million29 October 2025198,359 shares from 29 October 2025Merrill LynchStock BonusForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Sold, per Form 4: the same seller's open-market sales on Form 4 from the notice's date to 90 days after, added up, as they appear on the insiders page; a holder who files no Form 4, such as some large holders, never shows one. What is a Form 144?